1. Home
  2. LQDA vs HOG Comparison

LQDA vs HOG Comparison

Compare LQDA & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$37.80

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$24.08

Market Cap

2.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
HOG
Founded
2004
1903
Country
United States
United States
Employees
N/A
6400
Industry
Biotechnology: Pharmaceutical Preparations
Motor Vehicles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.5B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
LQDA
HOG
Price
$37.80
$24.08
Analyst Decision
Strong Buy
Hold
Analyst Count
11
7
Target Price
$41.00
$24.00
AVG Volume (30 Days)
1.1M
3.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
3.06%
EPS Growth
51.81
N/A
EPS
N/A
2.78
Revenue
$158,320,000.00
$4,473,175,000.00
Revenue This Year
$278.87
N/A
Revenue Next Year
$57.13
$3.79
P/E Ratio
N/A
$8.45
Revenue Growth
1031.18
N/A
52 Week Low
$11.85
$17.09
52 Week High
$46.67
$31.25

Technical Indicators

Market Signals
Indicator
LQDA
HOG
Relative Strength Index (RSI) 49.78 76.67
Support Level $31.75 $22.75
Resistance Level $39.19 $24.98
Average True Range (ATR) 2.12 0.80
MACD 0.09 0.27
Stochastic Oscillator 37.52 97.56

Price Performance

Historical Comparison
LQDA
HOG

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

Share on Social Networks: